The broad spectrum of beta-thalassemia (βThal) mutations may result in mild reduction (β ++), severe reduction (β +) or complete absence (β 0) of beta-globin synthesis. βThal heterozygotes eligible for blood donation are "good storers" in terms of red blood cell (RBC) fragility, proteostasis and redox parameters of storage lesion. However, it has not been examined if heterogeneity in genetic backgrounds among βThal-trait donors affects their RBC storability profile. For this purpose, a paired analysis of physiological and omics parameters was performed in freshly drawn blood and CPD/SAGM-stored RBCs donated by eligible volunteers of β ++ (N = 4), β + (N = 9) and β 0 (N = 2) mutation-based phenotypes. Compared to β +, β ++ RBCs were characterized by significantly lower RDW and HbA2 but higher hematocrit, MCV and NADPH levels in vivo. Moreover, they had lower levels of reactive oxygen species and markers of oxidative stress, already from baseline. Interestingly, their lower myosin and arginase membrane levels were accompanied by increased cellular fragility and arginine values. Proteostasis markers (proteasomal activity and/or chaperoning-protein membrane-binding) seem to be also diminished in β ++ as opposed to the other two phenotypic groups. Overall, despite the low number of samples in the sub-cohorts, it seems that the second level of genetic variability among the group of βThal-trait donors is reflected not only in the physiological features of RBCs in vivo, but almost equally in their storability profiles. Mutations that only slightly affect the globin chain equilibrium direct RBCs towards phenotypes closer to the average control, at least in terms of fragility indices and proteostatic dynamics.
Keywords: beta-thalassemia trait; genetic variability; omics; red blood cells; storage lesion.
Copyright © 2022 Anastasiadi, Tzounakas, Dzieciatkowska, Arvaniti, Papageorgiou, Papassideri, Stamoulis, D’Alessandro, Kriebardis and Antonelou.